FibroGen Inc

FibroGen Inc (FGEN) SEC filings

FibroGen Inc (FGEN) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported FGEN revenue for 2025-09-30 was $1.1M. Net income was $197.7M. Revenue was down 20.2% from 2025-06-30 to 2025-09-30. FGEN currently screens at market cap $39.3M. The FGEN filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what FibroGen Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

0

10-K

0

10-Q

0

8-K

0

Form 4

No cached SEC filings for FGEN yet. When an 8-K lands, this page will show the exhibit headline and numbers.

Open EDGAR

EDGAR is the official archive. Browse all FGEN filings.

Frequently asked questions

What did FGEN just say?

FGEN cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.

Where are FGEN SEC filings?

0 cached filings are on this page. EDGAR remains the official archive.

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.